Anzeige
Mehr »
Login
Samstag, 19.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Gold auf 4.000 USD? Goldman Sachs sagen Ja - und bei Forge sitzt der Ex-CFO von Newmont mit am Tisch
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALU7 | ISIN: US1266541028 | Ticker-Symbol: N/A
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart

Aktuelle News zur CV SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.03.CV Sciences, Inc. (PNK:CVSI) Q4 2024 Earnings Call Transcript1
27.03.CV Sciences, Inc. - 10-K, Annual Report1
27.03.CV Sciences targets profitability with new product lines and M&A strategy in 20253
27.03.CV Sciences, Inc. - 8-K, Current Report2
27.03.CV Sciences Non-GAAP EPS of -$0.01, revenue of $15.71M3
27.03.CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results399SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
26.03.CV Sciences debuts Lunar Fox plant-based food line1
CV SCIENCES Aktie jetzt für 0€ handeln
26.03.CV Sciences startet pflanzliche Lebensmittellinie Lunar Fox2
26.03.CV Sciences, Inc.: CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods781The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CVSI)...
► Artikel lesen
20.03.CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025253SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...
► Artikel lesen
20.02.CV Sciences, Inc. - 8-K, Current Report-
11.02.CV Sciences, Inc. - 8-K, Current Report-
05.02.CV Sciences, Inc.: CV Sciences Unveils New Aura Collection THC Fizz Tablets170The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home. SAN DIEGO, CA / ACCESS Newswire / February 5, 2025...
► Artikel lesen
22.11.24Hemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To Know9
21.11.24CV Sciences to acquire Extract Labs in strategic expansion4
21.11.24CV Sciences enters into agreement to acquire Extract Labs2
21.11.24CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs133SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company...
► Artikel lesen
21.11.24CV Sciences, Inc. - 8-K, Current Report-
14.11.24CV Sciences Q3: Revenue Stable Amid New Launches, Financing1
14.11.24CV Sciences, Inc. - 10-Q, Quarterly Report -
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1